If you suffer from Chronic Spontaneous Urticaria (CSU), which presents in the form of inflamed itchy wheals (hives) that develop spontaneously and persists for several weeks, you may be eligible to participate in this trial.
Trial 1: Ligelizumab (injection) for treating CSU
Participants: Aged 12 years of older with CSU
Status: Currently recruiting at Darlinghurst
More information: https://clinicaltrials.gov/ct2/show/study/NCT02649218